Tricyclic antidepressant overdose pathophysiology

Tricyclic antidepressant overdose Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Tricyclic Antidepressant Overdose from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricyclic antidepressant overdose pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricyclic antidepressant overdose pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricyclic antidepressant overdose pathophysiology

CDC on Tricyclic antidepressant overdose pathophysiology

Tricyclic antidepressant overdose pathophysiology in the news

Blogs on Tricyclic antidepressant overdose pathophysiology

Directions to Hospitals Treating Tricyclic antidepressant overdose

Risk calculators and risk factors for Tricyclic antidepressant overdose pathophysiology

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Raviteja Guddeti, M.B.B.S. [2]

## Overview

[edit | edit source]

Most of the toxic effects of TCAs are caused by four major pharmacological effects. TCAs have anticholinergic effects, cause excessive blockade of norepinephrine reuptake at the preganglionic synapse, direct alpha adrenergic blockade, and importantly they block sodium membrane channels with slowing of membrane depolarization, thus having quinidine like effects on the myocardium.[1]

## Pathophysiology

[edit | edit source]

### Toxicity

[edit | edit source]

Tricyclics have a narrow therapeutic index, i.e., the therapeutic dose is close to the toxic dose.[2] In the medical literature the lowest reported toxic dose is 6.7 mg per kg body weight. Although there are differences in toxicity with the drug class, ingestions of 10 to 20 mg per kilogram of body weight are a risk for moderate to severe poisoning, however, doses ranging from 1.5 to 5 mg/kg may even present a risk. Most poison control centers refer any case of TCA poisoning (especially in children) to a hospital for monitoring.[3] Factors that increase the risk of toxicity include advancing age, cardiac status, and concomitant use of other drugs.[4] However, serum drug levels are not useful for evaluating risk of arrhythmia or seizure in tricyclic overdose.[5] TCA levels >1000 ng/ml were associated with QT and QRS prolongation and convulsions.

## References

[edit | edit source]

1. ↑ Kerr G, McGuffie A, Wilkie S (2001). "Tricyclic antidepressant overdose: a review". Emerg Med J. 18 (4): 236–41. doi:10.1136/emj.18.4.236. PMC 1725608. PMID 11435353.CS1 maint: Multiple names: authors list (link)
2. ↑ Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, Wax PM, Manoguerra AS, Scharman EJ, Olson KR, Chyka PA, Christianson G, Troutman WG (2007). "Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management". Clin Toxicol (Phila). 45 (3): 203–33. doi:10.1080/15563650701226192. PMID 17453872.CS1 maint: Multiple names: authors list (link)
3. ↑ McFee R, Mofenson H, Caraccio T (2000). "A nationwide survey of the management of unintentional-low dose tricyclic antidepressant ingestions involving asymptomatic children: implications for the development of an evidence-based clinical guideline". J Toxicol Clin Toxicol. 38 (1): 15–9. doi:10.1081/CLT-100100910. PMID 10696919.CS1 maint: Multiple names: authors list (link)
4. ↑ Preskorn S, Irwin H (1982). "Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review". J Clin Psychiatry. 43 (4): 151–6. PMID 7068546.
5. ↑ Boehnert M, Lovejoy F (1985). "Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants". N Engl J Med. 313 (8): 474–9. doi:10.1056/NEJM198508223130804. PMID 4022081.

Template:WH Template:WS